Pulmonary mortality after high-dose oral busulfan and autologous stem cell transplant (ASCT) in patients with non-Hodgkin lymphoma (NHL).

被引：0
|
作者：
Kalaycio, M [1 ]
Pohlman, B [1 ]
Rybicki, L [1 ]
Sobecks, R [1 ]
Kuczkowski, E [1 ]
Andresen, S [1 ]
Brown, S [1 ]
Bolwell, B [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1764
引用
收藏
页码：501A / 502A
页数：2
相关论文
共 50 条
  • [1] High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era
    Ban-Hoefen, Makiko
    Friedberg, Jonathan W.
    Kelly, Jennifer L.
    Bernstein, Steven H.
    Liesveld, Jane L.
    Young, Faith
    Fisher, Richard I.
    Constine, Louis
    Becker, Michael
    Phillips, Gordon L., II
    BLOOD, 2010, 116 (21) : 992 - 992
  • [2] High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplant
    Kalaycio, Matt
    Pohlman, Brad
    Kuczkowski, Elizabeth
    Rybicki, Lisa
    Andresen, Steve
    Sobecks, Ronald
    Bolwell, Brian
    CLINICAL TRANSPLANTATION, 2006, 20 (06) : 783 - 787
  • [3] High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BLOOD, 2004, 104 (11) : 393B - 393B
  • [4] Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplant (ASCT)
    Ip, Andrew
    Switchenko, Jeffrey M.
    Graiser, Michael
    Koff, Jean
    Gupta, Vikas
    Lechowicz, MaryJo
    Al-Kadhimi, Zaid
    Nooka, Ajay
    Kaufman, Jonathan
    Lonial, Sagar
    Waller, Edmund K.
    Langston, Amelia A.
    Flowers, Christopher
    Cohen, Jonathon B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S135 - S136
  • [5] Experience with yttrium 90 ibritumomab tiuxetan after autologous stem cell transplant (ASCT) in patients with non-Hodgkin's lymphoma (NHL).
    Joyce, J
    Schuster, MW
    McCook, B
    Torok, F
    Avril, N
    Vidnovic, N
    Jacobs, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 602S - 602S
  • [6] High dose therapy with autologous stem cell transplant (ASCT) for non-Hodgkin's lymphoma (NHL) in elderly patients. A single institution retrospective study.
    Buadi, FK
    Micallef, IN
    Ansell, SM
    Porrata, LF
    Inwards, DJ
    BLOOD, 2003, 102 (11) : 736A - 737A
  • [7] High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era
    Ban-Hoefen, Makiko
    Kelly, Jennifer L.
    Bernstein, Steven H.
    Liesveld, Jane
    Constine, Louis
    Becker, Michael
    Milner, Laurie
    Phillips, Gordon
    Friedberg, Jonathan W.
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 830 - 835
  • [8] Pharmacokinetic-Guided Therapeutic Dose Monitoring (TDM) of Busulfan Reduces Relapse of Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (ASCT)
    Hill, Brian T.
    Rybicki, Lisa
    Urban, Theresa A.
    Lucerna, Mariana
    Jagadeesh, Deepa
    Gerds, Aaron T.
    Dean, Robert M.
    Sobecks, Ronald M.
    Pohlman, Brad
    Bolwell, Brian
    Kalaycio, Matt E.
    Hamilton, Betty K.
    Copelan, Edward A.
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [9] PHASE 2 TRIAL OF HIGH-DOSE GEMCITABINE, BUSULFAN AND MELPHALAN WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR PATIENTS WITH REFRACTORY HODGKIN'S LYMPHOMA (HL)
    Nieto, Y.
    Popat, U.
    Anderlini, P.
    Hosing, C.
    Andersson, B.
    Valdez, B.
    Shpall, E. J.
    Ahmed, S.
    Qazilbash, M.
    Kebriaei, P.
    Alousi, A.
    Bassett, R.
    Oki, Y.
    Fanale, M.
    Hagemeister, F.
    Dabaja, B.
    Reed, V.
    Pinnix, C.
    Tewari, P.
    Worth, L.
    Champlin, R.
    Jones, R. B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S166 - S166
  • [10] Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients with Non-Hodgkin's Lymphoma (NHL)
    Jagadeesh, Deepa
    Rybicki, Lisa
    Abounader, Lonna
    Liu, Hein
    Dean, Robert M.
    Hill, Brian T.
    Sobecks, Ronald M.
    Gerds, Aaron
    Hamilton, Betty Ky
    Pohlman, Brad
    Kalaycio, Matt E.
    Bolwell, Brian
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S224 - S225
12345